コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 children and adults with Leber's congenital amaurosis.
2 of the childhood blindness Leber congenital amaurosis.
3 e site in two siblings with Leber congenital amaurosis.
4 tential therapies for human Leber congenital amaurosis.
5 out mice and in humans with Leber congenital amaurosis.
6 g disease of infancy called Leber congenital amaurosis.
7 utations in RPGRIP1 cause Leber's congenital amaurosis.
8 Mutations in RPGRIP1 cause Leber congenital amaurosis.
9 ng retinitis pigmentosa and Leber congenital amaurosis.
10 e blinding disease called Leber's congenital amaurosis.
11 s, retinitis pigmentosa and Leber congenital amaurosis.
12 le those in RPGRIP1 lead to Leber congenital amaurosis.
13 d to the retinal dystrophy, Leber congenital amaurosis.
14 s carrying the diagnosis of Leber congenital amaurosis.
15 inal degenerations known as Leber congenital amaurosis.
16 the diagnostic category of Leber congenital amaurosis.
17 dystrophy and with de novo Leber congenital amaurosis.
18 cken is a model for human Leber's congenital amaurosis.
19 degenerations, including Leber's congenital amaurosis.
20 nt retinitis pigmentosa and Leber congenital amaurosis.
21 ng retinitis pigmentosa and Leber congenital amaurosis.
22 Two patients (5.1%) had Leber congenital amaurosis.
23 a phenotype that resembles Leber congenital amaurosis.
24 ss of enzymatic function in Leber congenital amaurosis.
25 described in 1 patient with Leber congenital amaurosis.
26 generation in some forms of Leber congenital amaurosis.
27 6) and recessive forms of Leber's congenital amaurosis.
28 tinal dystrophy, similar to Leber congenital amaurosis.
29 retinitis pigmentosa and Leber's congenital amaurosis.
32 65 mutation correction in a Leber congenital amaurosis 2 (LCA2) patient-specific iPSC line using enFn
34 he most severe phenotype of Leber congenital amaurosis, 7 patients with biallelic GUCY2D had a later
35 e-rod dystrophy, 22.2% with Leber congenital amaurosis, 7.4% with early-onset retinitis pigmentosa, a
37 These conditions range from Leber congenital amaurosis (a severe cone and rod degeneration of childho
38 mouse strain and in human Leber's congenital amaurosis, a congenital retinal dystrophy that results i
39 P1 have been shown to cause Leber congenital amaurosis, a group of retinal dystrophies that represent
40 Mutations in RPE65 cause Leber's congenital amaurosis, a progressive retinal degenerative disease th
41 Mutations in AIPL1 cause Leber congenital amaurosis, a severe early-onset retinopathy that leads t
42 1 gene were associated with Leber congenital amaurosis, a severe retinal degenerative disease that ca
44 report development of ipsilateral transient amaurosis accompanied with mydriasis and both, direct an
45 ropathy), ocular disorders (Leber congenital amaurosis, age-related macular degeneration [AMD], choro
46 Retinal gene therapy for Leber's congenital amaurosis, an autosomal recessive childhood blindness, h
48 ons within the gene lead to Leber Congenital Amaurosis and autosomal recessive retinitis pigmentosa i
50 rum of TULP1 mutations from Leber congenital amaurosis and early-onset retinitis pigmentosa to cone-d
57 s in AIPL1 may present with Leber congenital amaurosis and residual ERGs characterized by slow insens
58 nditions in humans, such as Leber congenital amaurosis and retinitis pigmentosa (RP), are attributed
60 ents (aged >/=6 years) with Leber congenital amaurosis and RPE65 or LRAT mutations at McGill Universi
61 mentosa collectively termed Leber congenital amaurosis and segregates naturally in the collie breed o
62 rable models for studies of Leber congenital amaurosis and that the destructive cone opsin mistraffic
63 ential therapies for NMNAT1-Leber congenital amaurosis, and conducting in situ studies on NMNAT1 func
64 tronic mutations that cause Leber congenital amaurosis, and we speculate that reduced dosage of corre
66 as retinitis pigmentosa and Leber congenital amaurosis, are a leading cause of untreatable blindness
68 ant retinitis pigmentosa, Leber's congenital amaurosis, autosomal dominant cone degeneration, central
70 ions in that region causing Leber congenital amaurosis blindness disrupt activation of the cyclase by
71 an Rpe65-/- mouse model of Leber congenital amaurosis but does not protect from cone degeneration.
72 on in humans diagnosed with Leber congenital amaurosis caused by mutations in the RPE65 gene, an inhe
74 attributed previously to Leber's congenital amaurosis, central areolar choroidal dystrophy and domin
75 5(-/-) mouse, a model for Leber's congenital amaurosis, cones degenerate much more rapidly than rods.
78 tis pigmentosa, or dominant congenital Leber amaurosis (early-onset retinitis pigmentosa), and we ide
79 Mutations associated with Leber congenital amaurosis/early-onset blindness cause partial to total l
80 unrelated patients who had Leber congenital amaurosis for mutations in RPGRIP1 and found recessive m
83 s in the vertebrobasilar territory; atypical amaurosis fugax and limb-shaking as TNAs in the carotid
85 t with stroke, transient ischemic attack, or amaurosis fugax had occurred in the neurovascular territ
86 had a stroke, transient ischemic attack, or amaurosis fugax in the 180 days before enrollment) and w
87 ateral stroke, transient ischaemic attack or amaurosis fugax) as potential risks for CHS (all p</=0.1
88 ymptoms (stroke, transient ischemic attacks, amaurosis fugax) than in asymptomatic patients, and expr
89 vents (transient ischemic attack, stroke, or amaurosis fugax), due for carotid endarterectomy, were p
90 vents (transient ischemic attack, stroke, or amaurosis fugax), due for carotid endarterectomy, were p
91 ascular disease, and 26 (24%) presented with amaurosis fugax, 54 (49%) with transient ischemic attack
92 , acute onset of diffuse neurologic deficit, amaurosis fugax, acute renal failure, gut ischemia, live
93 tic or had had a transient ischaemic attack, amaurosis fugax, or a minor stroke were eligible for CRE
96 rs) with RPE65-associated Leber's congenital amaurosis given one subretinal injection of adeno-associ
97 mouse, used as a model for Leber congenital amaurosis, has slow rod degeneration and rapid cone loss
99 ials for the treatment of Leber's congenital amaurosis have provided evidence for successful in-vivo
100 -deficient mice, a model of Leber congenital amaurosis, have no rod photopigment and severely impaire
101 1 bp] mutation) and simplex Leber congenital amaurosis in two families (E168 [delta2 bp], G217 [delta
102 resents the case of a patient with bilateral amaurosis in whom the diagnosis of giant cell arteritis
103 ull allele is affected with Leber congenital amaurosis, it was surprising that her father, who had no
104 Rpe65(-/-) mouse model of Lebers congenital amaurosis (LCA) and in a Cpfl1 mouse with Pde6c defect m
107 on of Crx that causes human Leber congenital amaurosis (LCA) and resides within the NLS resulted in t
109 with two retinal disorders; Leber congenital amaurosis (LCA) and snowflake vitreoretinal degeneration
110 s supporting a diagnosis of Leber congential amaurosis (LCA) as an infant, her level of acuity and fu
111 res for a clinical trial of Leber congenital amaurosis (LCA) associated with mutations in the GUCY2D
113 is responsible for >10% of Leber congenital amaurosis (LCA) cases worldwide; LCA is characterized by
115 subjects and patients with Leber congenital amaurosis (LCA) caused by mutations in GUCY2D, the gene
118 in the LCA5 gene underlying Leber congenital amaurosis (LCA) in the Spanish population and to describ
119 an Lrat(-/-) mouse model of Leber congenital amaurosis (LCA) in which retinal light sensitivity and o
135 evastating blinding disease Leber congenital amaurosis (LCA) to Senior-Loken syndrome, Joubert syndro
136 mouse, which is a model of Leber congenital amaurosis (LCA) type 10 caused by mutations in the cilia
137 s typically associated with Leber congenital amaurosis (LCA) type I, with a number of patients retain
138 etinitis pigmentosa (RP) or Leber congenital amaurosis (LCA) using melting curve analysis and DNA seq
139 -deficient mice [a model of Leber congenital amaurosis (LCA) with rapid cone loss] and cone photorece
140 36 patients affected with Leber's congenital amaurosis (LCA), 62 with autosomal recessive retinitis p
141 (Aipl1) are associated with Leber congenital amaurosis (LCA), a childhood blinding disease with early
142 morphic mutations result in Leber congenital amaurosis (LCA), a form of early-onset retinal dystrophy
143 l manifestations, including Leber congenital amaurosis (LCA), a hereditary cause of blindness due to
145 gene coding for AIPL1 cause Leber congenital amaurosis (LCA), a severe form of childhood blindness.
147 retinal synthesis and cause Leber congenital amaurosis (LCA), a severe hereditary blindness occurring
148 nsferase (LRAT) genes cause Leber congenital amaurosis (LCA), a severe visual impairment in humans.
149 been found in patients with Leber congenital amaurosis (LCA), a severe, early-onset form of retinal d
150 nd 11-cis-retinal and cause Leber congenital amaurosis (LCA), a severe, early-onset retinal dystrophy
151 as retinitis pigmentosa and Leber congenital amaurosis (LCA), affects approximately 1/3000 of the pop
154 -deficient mouse models for Leber Congenital Amaurosis (LCA), but exogenous supplementation of the na
155 tinitis pigmentosa (RP) and Leber congenital amaurosis (LCA), comprise a group of disorders showing h
156 rm of blindness at birth, Leber's congenital amaurosis (LCA), is inherited in an autosomal recessive
157 GRIP1) gene cause recessive Leber congenital amaurosis (LCA), juvenile retinitis pigmentosa (RP) and
158 ed with autosomal recessive Leber congenital amaurosis (LCA), the most severe form of inherited retin
159 retinal recycling and cause Leber congenital amaurosis (LCA), the most severe retinal dystrophy in ea
161 ly disrupted in humans with Leber congenital amaurosis (LCA), which is caused by mutations in RPE65,
184 -nine individuals (88%) had Leber congenital amaurosis (LCA)/early-onset severe retinal dystrophy.
188 indness (CSNB), recessive Leber's congenital amaurosis (LCA1), and dominant cone-rod dystrophy-6 (COR
189 J13 gene are known to cause Leber congenital amaurosis (LCA16), an inherited pediatric blindness.
192 retinitis pigmentosa, and Leber's congenital amaurosis matched well with data from previous studies.
193 R 4.87 [95% CI 4.07-5.82]), Leber congenital amaurosis (OR 2.41 [95% CI 1.02-5.71]), sleep apnea (OR
195 in retinitis pigmentosa and Leber congenital amaurosis patients did not reveal any obvious disease-ca
197 W708R and I734T, linked to Leber congenital amaurosis prevented binding of both GCAP1-GFP and GCAP2-
198 suggest a model for INPP5E-Leber congenital amaurosis, proposing how deletion of INPP5E may interrup
199 animal ciliopathy model of Leber congenital amaurosis provides a path for translation to human treat
200 tations in NPHP5, a form of Leber congenital amaurosis, results in abnormal development, dysfunction,
201 lated macular degeneration, Leber congenital amaurosis, retinitis pigmentosa, and cone-rod dystrophy.
202 dness in animal models of Leber's congenital amaurosis, several groups proceeded with adeno-associate
203 d histories consistent with Leber congenital amaurosis (severely reduced vision, poorly responsive pu
204 intellectual disability and Leber congenital amaurosis (SHILCA), as well as some brain anomalies that
206 gous state in patients with Leber congenital amaurosis than predicted based on its heterozygosity fre
207 one degeneration resembling Leber congenital amaurosis that is nearly completed by postnatal day 21 (
208 f RPE65 are associated with Leber congenital amaurosis that results in rod and cone photoreceptor deg
209 na of two genetic models of Leber congenital amaurosis, the Crb1(rd8/rd8) and Gucy2e(-/-) mouse.
210 (-/-) mice, models of human Leber congenital amaurosis, the retinoid cycle is disrupted and 11-cis-re
211 eterogeneous and present as Leber Congenital Amaurosis, the severest form of early-onset retinal dyst
212 eles of CRX appear to cause Leber congenital amaurosis through a recessive or multigenic mechanism.
214 um of CRX-RDs, ranging from Leber congenital amaurosis to mild late-onset maculopathy resembling occu
215 sis of this animal model of Leber congenital amaurosis type 1 (LCA1), a disease that results from nul
216 Mutations in GUCY2D cause Leber congenital amaurosis type 1 (LCA1), an autosomal recessive human re
220 d to the congenital disease Leber congenital amaurosis Type 2 (LCA2) characterized by the early onset
221 p of 5 patients affected by Leber congenital amaurosis type 2 (LCA2) treated with a single unilateral
222 ombined Immunodeficiency, Leber's Congenital Amaurosis Type 2 and in cancer immunotherapy trials for
223 lize PDE6 and thereby cause Leber congenital amaurosis type 4 (LCA4), a severe form of childhood blin
224 nherited retinal dystrophy, Leber congenital amaurosis type 4 (LCA4), that manifests as the loss of v
225 epithelium of patients with Leber congenital amaurosis was noted as one of the most important clinica
226 viously was implicated in Leber's congenital amaurosis, was screened for mutations within this family
228 rly-onset retinal dystrophy Leber congenital amaurosis, whereas RDH11 has not been associated with hu
230 reatment of mouse models of Leber congenital amaurosis with 9-cis-BC and 9-cis-retinyl-acetate, a wel
231 e mammalian model of NMNAT1-Leber congenital amaurosis would assist in determining the mechanisms thr
232 for retinitis pigmentosa, Leber's congenital amaurosis, X-linked retinoschisis, Best's disease, Starg